Medicare Enrolled

Dr. Michael Naarendorp, M.D.

Rheumatology · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
51 SAINT NICHOLAS AVE, New York, NY 10026
2123605752
In practice since 2006 (20 years)
NPI: 1740256908 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Naarendorp from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Naarendorp? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Naarendorp

Dr. Michael Naarendorp is a rheumatology specialist in New York, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Naarendorp performed 228 Medicare services across 80 unique beneficiaries.

Between the years covered by Open Payments, Dr. Naarendorp received a total of $28,887 from 44 pharmaceutical and/or device companies across 977 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Naarendorp is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 228 Medicare services $28,887 industry payments

Medicare Practice Summary

Medicare Utilization ↗
228
Medicare services
Bottom 24% in NY for rheumatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
80
Unique beneficiaries
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~11 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 120 $106 $194
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
 95 $77 $130
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
 13 $102 $193
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$28,887
Total received (2018-2024)
Avg $4,127/year across 7 years
Top 16% in NY for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
977
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,970 (83.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,779 (9.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,138 (7.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,489
2023
$3,981
2022
$5,310
2021
$5,181
2020
$1,566
2019
$4,181
2018
$4,179

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$889
AstraZeneca Pharmaceuticals LP
$721
ABBVIE INC.
$543
GlaxoSmithKline, LLC.
$456
Aurinia Pharma U.S., Inc.
$408
PFIZER INC.
$315
Lilly USA, LLC
$210
Janssen Biotech, Inc.
$169
E.R. Squibb & Sons, L.L.C.
$153
Genentech USA, Inc.
$134
UCB, Inc.
$113
Novartis Pharmaceuticals Corporation
$108
ANI Pharmaceuticals, Inc.
$105
GENZYME CORPORATION
$94
Alexion Pharmaceuticals, Inc.
$27
Organon Llc
$23
SCILEX PHARMACEUTICALS INC.
$21
Top 3 companies account for 48.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$5,267
Aurinia Pharma U.S., Inc.
$3,624
Janssen Biotech, Inc.
$3,327
AstraZeneca Pharmaceuticals LP
$2,166
ABBVIE INC.
$2,021
UCB, Inc.
$1,733
Novartis Pharmaceuticals Corporation
$1,341
PFIZER INC.
$1,301
GlaxoSmithKline, LLC.
$1,078
Genentech USA, Inc.
$801
AbbVie, Inc.
$739
Boehringer Ingelheim Pharmaceuticals, Inc.
$556
Lilly USA, LLC
$546
Regeneron Healthcare Solutions, Inc.
$471
Mallinckrodt Hospital Products Inc.
$430
AbbVie Inc.
$365
Alexion Pharmaceuticals, Inc.
$359
Mallinckrodt LLC
$348
E.R. Squibb & Sons, L.L.C.
$296
Mallinckrodt Enterprises LLC
$272
Horizon Therapeutics plc
$255
Flexion Therapeutics, Inc.
$205
Antares Pharma, Inc.
$202
GENZYME CORPORATION
$179
Janssen Scientific Affairs, LLC
$166
Celgene Corporation
$132
ANI Pharmaceuticals, Inc.
$105
Takeda Pharmaceuticals U.S.A., Inc.
$91
MEDAC PHARMA, INC.
$75
Horizon Pharma plc
$56
MEDEXUS PHARMA, INC.
$54
Organon LLC
$43
Avion Pharmaceuticals
$36
Ironwood Pharmaceuticals, Inc
$33
Kiniksa Pharmaceuticals, Ltd.
$32
SANOFI-AVENTIS U.S. LLC
$25
Actelion Pharmaceuticals US, Inc.
$25
Organon Llc
$23
Radius Health, Inc.
$22
SCILEX PHARMACEUTICALS INC.
$21
Bioventus LLC
$19
Merck Sharp & Dohme Corporation
$18
Oxford Immunotec USA Inc
$18
Cumberland Pharmaceuticals, Inc.
$12
Top 3 companies account for 42.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · Arcalyst · BENLYSTA · Balcoltra · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DUEXIS · DUZALLO · Durolane · ENTRESTO · EVENITY · Enbrel · FORTEO · HADLIMA · HUMIRA · Humira · ILARIS · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · LINZESS · LUPKYNIS · LYRICA · NUCALA · OFEV · OLUMIANT · OPSUMIT MACITENTAN · ORENCIA · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REDITREX · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Repatha · Rinvoq · Rituxan · SAPHNELO · SHINGRIX · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · Strensiq · T-SPOT.TB8 · TALTZ · TAVNEOS · TREMFYA · Tymlos · Uloric · VIMOVO · XELJANZ · XYOSTED · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (83%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in New York?
Compare rheumatologists in the New York area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
386
Per 100K population
23.7
County median income
$104,553
Nearest hospital
MOUNT SINAI HOSPITAL
0.8 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Naarendorp is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 16% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Naarendorp experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Naarendorp performed 120 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Naarendorp receive payments from pharmaceutical companies?
Yes. Dr. Naarendorp received a total of $28,887 from 44 companies across 977 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Naarendorp's costs compare to other rheumatologists in New York?
Dr. Naarendorp's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Naarendorp) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Rheumatologists in New York
Browse rheumatologists in New York ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in NY
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in NY
Which NY rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Aurinia Pharma U.S., Inc. Payments to Doctors
See all physicians who received payments from Aurinia Pharma U.S., Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →